Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium - Related Studies

Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

This study is ongoing, but not recruiting participants.

Study NCT00003376. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Bladder Cancer
		Urethral Cancer

2	Additional conditions recognized in this trial
		Carcinoma, Transitional Cell
		Kidney Neoplasms
		Ureteral Neoplasms
		Urethral Neoplasms
		Urinary Bladder Neoplasms

3	More general conditions related to this trial
		Carcinoma
		Kidney Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Ureteral Diseases
		Urethral Diseases
		Urinary Bladder Diseases
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms

4	Interventions listed in this trial
		carboplatin
		cisplatin
		doxorubicin hydrochloride
		methotrexate
		paclitaxel
		vinblastine

5	Additional drug interventions recognized in this trial
		Doxorubicin

6	More general drug interventions related to this trial
		Abortifacient Agents
		Abortifacient Agents, Nonsteroidal
		Antibiotics, Antineoplastic
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Dermatologic Agents
		Enzyme Inhibitors
		Folic Acid Antagonists
		Immunologic Factors
		Immunosuppressive Agents
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Radiation-Sensitizing Agents
		Reproductive Control Agents
		Therapeutic Uses
		Tubulin Modulators

7	Sponsors listed in this trial
		Eastern Cooperative Oncology Group
		National Cancer Institute (NCI)
		Cancer and Leukemia Group B